Maridea Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Maridea Wealth Management's BTAL Position: Q2 2026 in Review
Maridea Wealth Management opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 105,600 shares worth $1.18M. The stake represents 0.13% of the portfolio and ranks #179 among its holdings. This is a return to the name: Maridea Wealth Management previously reported a position in BTAL as recently as Q2 2025.
Maridea Wealth Management first reported a position in BTAL in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.62M in Q1 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Maridea Wealth Management held 105,600 shares of AGF US Market Neutral Anti-Beta Fund worth $1.18M as of Q2 2026.
- AGF US Market Neutral Anti-Beta Fund was a new Maridea Wealth Management position in Q2 2026.
- AGF US Market Neutral Anti-Beta Fund made up 0.13% of Maridea Wealth Management's portfolio in Q2 2026, its #179 holding.
- Maridea Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and has held it in 4 quarters since.
- Maridea Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $4.62M in Q1 2025.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Maridea Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.